Der var ingen forskel mellem OPTRUMA - og placebo- behandlede kvinder i forekomsten af vaginal blødning (pletblødning) eller vaginalt udflåd.
There was no difference between OPTRUMA and placebo treated women in the incidences of vaginal bleeding (spotting) or vaginal discharge.